FDA Inspection
CooperSurgical, Inc.CooperSurgical, Inc. – FDA Inspection, Mar 4, 2022
Record Details
This FDA Inspection record concerns CooperSurgical, Inc., with an inspection on March 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- CooperSurgical, Inc.
- Inspection Date
- March 4, 2022
- Product Type
- Drugs
View Company Profile
ID · 3ca27c07-7c90-4c2d-84a4-a516bcbbfccc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1163752
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.67(b)Written procedures fail to include
- 21 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CooperSurgical, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| March 24, 2026 | Not classified | New York District Office | |
| February 1, 2024 | VAI | New Drug Evaluation | |
| August 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 21, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CooperSurgical, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.